TDI-34

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameTDI-34
Drug Alias NameGene therapy program (ALS Therapy Development Foundation)TDI-0034TDI-0041TDI-0038TDI-34 +[8] 
ClassificationBiologics
Mechanisms of ActionNeuroprotectantsNerve growth factor receptors agonists
TargetsNerve growth factor receptors
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesALS Therapy Development Foundation Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesALS Therapy Development Foundation Inc
Active IndicationsN/A
Inactive IndicationsAmyotrophic Lateral Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A